Skip to content
WeChat· 国际科学·· 6 hours agoPickScore76

Guangzhou Medical University team reports SLC52A2-mediated tumor competition for vitamin B2 drives T cell ferroptosis in Cell

In brief

Yingjie Bian's team reports in Cell that tumor cells preferentially take up vitamin B2 from the microenvironment via SLC52A2, creating metabolic competition with T cells and driving their ferroptosis. Knocking out SLC52A2 in tumors restored T cell antitumor function without affecting tumor proliferation itself.

Why it matters

The paper defines the SLC52A2 mechanism by which tumors compete with T cells for vitamin B2, and knocking out the transporter restores T cell function without affecting tumor proliferation.

Source: WeChat · mp.weixin.qq.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org